Shen, Y., Lu, X., Ma, X., Liu, W., Ye, D. (2025). Updated efficacy and safety results from ReBirth, a phase II study of risk-based bladder-sparing therapy for MIBC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4586